Anti-CD44 Therapeutic Antibody (Bivatuzumab)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD44. Bivatuzumab is a humanized monoclonal antibody against CD44 v6. It has been chemically linked to various radioisotopes for use in radiotherapy for, e.g. inoperable recurrent or metastatic head and neck cancer. It has also been linked to a cytotoxic drug mertansine to form bivatuzumab mertansine.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-727 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD44 |
| Species Reactivity | Human |
| Type | IgG1 |
| Applications | ELISA, FC, IP, FuncS, IF, Neut, ICC, Activ |
| Storage | At -20°C for one year. |